Consistently, we observed higher levels of BRD4 protein abundance in MV4-11 (AML) and MKN45 (gastric cancer) compared with A549 (lung cancer) and HepG2 (liver cancer) cells (Figure 3(B)). This evidence concerns the gene BRD4 and acute myeloid leukemia.